Preston Klassen
2015 - Orexigen Therapeutics
In 2015, Preston Klassen earned a total compensation of $1.3M as Executive Vice President, Global Product Development at Orexigen Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $134,767 |
|---|---|
| Option Awards | $727,331 |
| Salary | $390,628 |
| Other | $180 |
| Total | $1,252,906 |
Klassen received $727.3K in option awards, accounting for 58% of the total pay in 2015.
Klassen also received $134.8K in non-equity incentive plan, $390.6K in salary and $180 in other compensation.
Rankings
In 2015, Preston Klassen's compensation ranked 6,845th out of 13,638 executives tracked by ExecPay. In other words, Klassen earned more than 49.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,845 out of 13,638 | 50th |
Division Manufacturing | 2,580 out of 5,187 | 50th |
Major group Chemicals And Allied Products | 928 out of 1,857 | 50th |
Industry group Drugs | 747 out of 1,531 | 51st |
Industry Pharmaceutical Preparations | 581 out of 1,179 | 51st |
Source: SEC filing on May 27, 2016.
Klassen's colleagues
We found five more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2015.
2015
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2015
Thomas Cannell
Orexigen Therapeutics
Chief Operating Officer
2015
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
2015
Heather Turner
Orexigen Therapeutics
General Counsel
2015
Thomas Lynch
Orexigen Therapeutics